| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/17/2010 | US20100152180 4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP) |
| 06/17/2010 | US20100152167 Pyrimidine derivatives |
| 06/17/2010 | US20100152154 Novel platinum compounds for treating cancer |
| 06/17/2010 | US20100152142 Crystalline form ii of tigecycline and processes for preparation thereof |
| 06/17/2010 | US20100152133 Use of chitosans to increase nail growth rate |
| 06/17/2010 | US20100152128 Antiviral Agents |
| 06/17/2010 | US20100152126 Beta-L-2'-Deoxy-Nucleosides for the Treatment of Hepatitis B |
| 06/17/2010 | US20100152103 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication |
| 06/17/2010 | US20100152101 Triazol compounds for treating biofilm formation |
| 06/17/2010 | US20100152098 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof |
| 06/17/2010 | US20100151507 Cavity Induced Allosteric Modification Of Intermolecular Interactions And Methods Of Identifying Compounds That Effect The Same |
| 06/17/2010 | US20100151052 Compositions to alleviate herpes virus symptoms |
| 06/17/2010 | US20100151044 Use of isoosmotic seawater-based ionic solutions for manufacturing medical devices for the prevention of complications of the common cold or of the flu syndrome |
| 06/17/2010 | US20100151042 Materials and Methods for Treating Influenza Infections |
| 06/17/2010 | US20100151029 Anti-infectious hydrogel compositions |
| 06/17/2010 | US20100151026 Novel strain of lactobacillus crispatus |
| 06/17/2010 | US20100151024 Therapeutic agent for ulcerative colitis |
| 06/17/2010 | US20100151013 Gastric acid secretion inhibiting composition |
| 06/17/2010 | US20100151003 Egfr binding peptides and uses thereof |
| 06/17/2010 | US20100151001 Ethynylated heterodinucleoside phosphate analogs, method for the production thereof, and use thereof |
| 06/17/2010 | US20100150985 Dental Implant, Endodontic Instrument, and Dental Filling Material Coated with a Peptide-Based Antimicrobial and Methods of Using and Making the Same |
| 06/17/2010 | US20100150964 Polypeptides and methods for the specific detection of antibodies in patients with a borrelia infection |
| 06/17/2010 | US20100150963 Yeast-Based Therapeutic for Chronic Hepatitis C Infection |
| 06/17/2010 | US20100150962 Polypeptide fragments of the hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits |
| 06/17/2010 | US20100150960 Compositions and methods for chitosan enhanced immune response |
| 06/17/2010 | US20100150959 PCV 2-Based Methods and Compositions for the Treatment of Pigs |
| 06/17/2010 | US20100150957 Peptides for active anti-cytokine immunization |
| 06/17/2010 | US20100150956 Multicomponent vaccines |
| 06/17/2010 | US20100150954 Vaccines against influenza virus |
| 06/17/2010 | US20100150950 Human antibodies that bind cd70 and uses thereof |
| 06/17/2010 | US20100150943 Immunogenic compositions for gram positive bacteria |
| 06/17/2010 | US20100150941 Hemagglutinin antibody and uses thereof |
| 06/17/2010 | US20100150934 Botulinum antitoxin compositions and methods |
| 06/17/2010 | US20100150916 huTNFR1 Selective Antagonists |
| 06/17/2010 | US20100150896 Diaminoquinazoline inhibitors of dihydrofolate reductase |
| 06/17/2010 | US20100150867 Use of alpha-glucosidase inhibitors to treat alphavirus infections |
| 06/17/2010 | US20100150866 Hepatitis C Virus Inhibitors |
| 06/17/2010 | DE202009017847U1 Zusammensetzung zur Prävention und Behandlung von Virusinfektionen Composition for the prevention and treatment of viral infections |
| 06/17/2010 | CA2746690A1 Mixing lyophilised meningococcal vaccines with non-hib vaccines |
| 06/17/2010 | CA2746579A1 Mixing lyophilised meningococcal vaccines with d-t-pa vaccines |
| 06/17/2010 | CA2746574A1 Feed for preventing and/or treating diseases caused by clostridium bacterium in livestock, and agent against clostridium |
| 06/17/2010 | CA2746421A1 Antimicrobial molecules for treating multi-drug resistant and extensively drug resistant strains of mycobacterium |
| 06/17/2010 | CA2746276A1 Characterization of an antibiotic impregnated delivery system as an intracanal medicament in endodontic therapy |
| 06/17/2010 | CA2746264A1 New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
| 06/17/2010 | CA2746258A1 Deuterated compounds as hepatitis c virus (hcv) inhibitors |
| 06/17/2010 | CA2745725A1 2- (piperidin-1-yl) -4-azolyl-thiazole-5-carboxylic acid derivatives against bacterial infections |
| 06/17/2010 | CA2745523A1 Uracyl cyclopropyl nucleotides |
| 06/17/2010 | CA2745063A1 2- (piperidin-1-yl) -4-heterocyclyl-thiazole-5-carboxylic acid derivatives against bacterial infections |
| 06/17/2010 | CA2745052A1 Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines |
| 06/17/2010 | CA2744456A1 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives |
| 06/17/2010 | CA2742711A1 Polymorph ii of an antifungal compound |
| 06/16/2010 | EP2196930A1 Cavity induced allosteric modificatin of intermolecular interactions and methods of identifiying compounds that effect the same |
| 06/16/2010 | EP2196475A1 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION |
| 06/16/2010 | EP2196473A1 Mycobacterial antigens expressed during latency |
| 06/16/2010 | EP2196472A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems |
| 06/16/2010 | EP2196463A1 Preparation of 5,6-dimethylxanthone-4-acetic acid, the derivatives prepared and pharmaceutical formulations thereof |
| 06/16/2010 | EP2196453A1 Novel substituted aryl derivatives, their process of preparation and their therapeutical uses as anti-HIV agents |
| 06/16/2010 | EP2196218A2 Use of anti-TNFalpha antibodies and another drug |
| 06/16/2010 | EP2196217A1 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 06/16/2010 | EP2196216A1 New vaccine composition and use of surfactants as immuno-adjuvant |
| 06/16/2010 | EP2196211A1 Apolactoferrin compositions and methods of the use thereof for treating viral hepatitis c |
| 06/16/2010 | EP2196205A1 Topoisomerase poisons |
| 06/16/2010 | EP2195289A2 Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof ans intermediates thereto |
| 06/16/2010 | EP2195042A1 Antimicrobial gas-releasing ear drainage tubes |
| 06/16/2010 | EP2195022A1 Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof |
| 06/16/2010 | EP2195019A1 Method of eliciting an immune response against pandemic influenza virus |
| 06/16/2010 | EP2195018A1 Novel polysaccharide immunogens from clostridium difficile |
| 06/16/2010 | EP2195012A2 Use of a peptide as a therapeutic agent |
| 06/16/2010 | EP2195004A1 Method of inhibiting clostridium difficile by administration of oritavancin |
| 06/16/2010 | EP2194993A2 Non-invasive in vivo imaging and methods for treating type i diabetes |
| 06/16/2010 | EP2194976A1 Hepatitis c antiviral compositions and methods |
| 06/16/2010 | EP2194974A1 Anti-bacterial pyrocatechols and related methods |
| 06/16/2010 | EP1848448B1 Use of a bacterial lysate for the prevention of tuberculosis relapse |
| 06/16/2010 | EP1625847B1 Medical use of a tetrahydrotriazolo[4,3-a]pyrazine |
| 06/16/2010 | EP1364010B1 Immunomodulatory polynucleotides and methods of using the same |
| 06/16/2010 | EP1307233B1 Therapeutic polyanhydride compounds for drug delivery |
| 06/16/2010 | EP1244463B1 Agent which is anti-adhesive in relation to the pathogenic flora of the skin |
| 06/16/2010 | EP1234024B2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 06/16/2010 | CN1989141B Bicyclic heterocycles as HIV integrase inhibitors |
| 06/16/2010 | CN1938307B 9-substituted 8-oxoadenine compound |
| 06/16/2010 | CN1915997B New process for the preparation of vinyl-pyrrolidinone cephalosporine derivatives |
| 06/16/2010 | CN1904034B Novel bacterium and vaccine |
| 06/16/2010 | CN1903352B Medicine for treating beriberi |
| 06/16/2010 | CN1879672B Effective components of glabrous sarcandra herb - total polyphenol, its preparation method and application |
| 06/16/2010 | CN1867566B Aminopyrones and their use as ATM inhibitors |
| 06/16/2010 | CN1864691B Use of compound scalarafuran |
| 06/16/2010 | CN1857687B Hepatitis B treating Chinese herbal medicine |
| 06/16/2010 | CN1857281B Adefovir dipivoxil liposome injection and its preparing method |
| 06/16/2010 | CN1830978B Pyrazolo [4,3-c]-quinolin-3-one compound, preparation method and use thereof |
| 06/16/2010 | CN1822822B Saquinavir mesylate oral dosage form |
| 06/16/2010 | CN1787829B Composition against infection with rotavirus and process for producing the same |
| 06/16/2010 | CN1768140B A high-troughput diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS) |
| 06/16/2010 | CN1709505B Polyvalent bacteria capsule polysaccharide-protein conjugate combined vaccine |
| 06/16/2010 | CN1634981B A group of antibiotic peptides, method for preparation and use thereof |
| 06/16/2010 | CN1582333B Live vaccine and method of manufacture |
| 06/16/2010 | CN1512894B Monocyte specific particulate delivery carrier |
| 06/16/2010 | CN101743251A Peptides with anitfungal activity |
| 06/16/2010 | CN101743246A 2-oxo-2- (2-phenyl-5,6,7,8-tetrahydro-indolizin-3-yl) -acetamide derivatives and related compounds as antifungal agents |
| 06/16/2010 | CN101743006A Crystalline form of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2 pyrimidinyl]amino]benzonitrile |
| 06/16/2010 | CN101736406A Method for discovering active components of traditional Chinese medicine by metabolic forecast and virtual sieving |